Helsinn Group Grants Exclusive Licensing Rights to Menarini for Pracinostat

21 December 2018

RECORDATI AND HELSINN AGREEMENT FOR THE EXCLUSIVE COMMERCIALIZATION RIGHTS TO LEDAGA®

20 December 2018

Advitech’s new project: APIsTRENDS – a collection of reports

18 December 2018

Helsinn Group Announces new Permanent J Code for AKYNZEO® (fosnetupitant and palonosetron) for injection in the US

12 December 2018

Wound care: Nexodyn® AOS comes to fruition in Slovakia

12 December 2018

Helsinn and Mundipharma China Pharmaceutical Announce Approval of ALOXI® IV by the National Medical Products Administration (NMPA)Helsinn and Mundipharma China Pharmaceutical Announce Approval of ALOXI® IV by the National Medical Products Administration (NMPA)

3 December 2018

PKU GOLIKE® comes to fruition in Italy

29 November 2018

La farmaceutica ticinese a Madrid per la CPhI 2018

28 November 2018

Paolo Magri nominated as President of the Board of Directors of the Drug, Chemical & Associated Technologies Association (DCAT)

14 November 2018

Rare Diseases: Expected Benefits of a Physiological Absorption of Amino Acids in PKU management. PKU GOLIKE® by APR can play a role

6 November 2018